AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-87
Results: 1-25/87

Authors: ROTH JS FORD H TANAKA M MITSUYA H KELLEY JA
Citation: Js. Roth et al., DETERMINATION OF 2'-BETA-FLUORO-2',3'-DIDEOXYADENOSINE, AN EXPERIMENTAL ANTI-AIDS DRUG, IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical sciences and applications, 712(1-2), 1998, pp. 199-210

Authors: HARADA N HATA H YOSHIDA M SONIKI T NAGASAKI A KURIBAYASHI N KIMURA T MATSUZAKI H MITSUYA H
Citation: N. Harada et al., EXPRESSION OF BCL-2 FAMILY OF PROTEINS IN FRESH MYELOMA CELLS, Leukemia, 12(11), 1998, pp. 1817-1820

Authors: MARQUEZ VE EZZITOUNI A RUSS P SIDDIQUI MA FORD H FELDMAN RJ MITSUYA H GEORGE C BARCHI JJ
Citation: Ve. Marquez et al., LESSONS FROM THE PSEUDOROTATIONAL CYCLE - CONFORMATIONALLY RIGID AZT CARBOCYCLIC NUCLEOSIDES AND THEIR INTERACTION WITH REVERSE-TRANSCRIPTASE, Nucleosides & nucleotides, 17(9-11), 1998, pp. 1881-1884

Authors: MUELLER BU ANDERSON BD FARLEY MQ MURPHY R ZUCKERMAN J JAROSINSKI P GODWIN K MCCULLY CL MITSUYA H PIZZO PA BALIS FM
Citation: Bu. Mueller et al., PHARMACOKINETICS OF THE PROTEASE INHIBITOR KNI-272 IN PLASMA AND CEREBROSPINAL-FLUID IN NONHUMAN-PRIMATES AFTER INTRAVENOUS DOSING AND IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN AFTER INTRAVENOUS AND ORAL DOSING, Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1815-1818

Authors: REZENDE LF CURR K UENO T MITSUYA H PRASAD VR
Citation: Lf. Rezende et al., THE IMPACT OF MULTIDIDEOXYNUCLEOSIDE RESISTANCE-CONFERRING MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE ON POLYMERASE FIDELITY AND ERROR SPECIFICITY, Journal of virology, 72(4), 1998, pp. 2890-2895

Authors: KAVLICK MF WYVILL K YARCHOAN R MITSUYA H
Citation: Mf. Kavlick et al., EMERGENCE OF MULTI-DIDEOXYNUCLEOSIDE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS, VIRAL SEQUENCE VARIATION, AND DISEASE PROGRESSION IN PATIENTS RECEIVING ANTIRETROVIRAL CHEMOTHERAPY, The Journal of infectious diseases, 177(6), 1998, pp. 1506-1513

Authors: MAEDA Y VENZON DJ MITSUYA H
Citation: Y. Maeda et al., ALTERED DRUG-SENSITIVITY, FITNESS, AND EVOLUTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH POL GENE-MUTATIONS CONFERRING MULTI-DIDEOXYNUCLEOSIDE RESISTANCE, The Journal of infectious diseases, 177(5), 1998, pp. 1207-1213

Authors: GAO WY ZHOU BS JOHNS DG MITSUYA H YEN Y
Citation: Wy. Gao et al., ROLE OF THE M2 SUBUNIT OF RIBONUCLEOTIDE REDUCTASE IN REGULATION BY HYDROXYUREA OF THE ACTIVITY OF THE ANTI-HIV-1 AGENT 2',3'-DIDEOXYINOSINE, Biochemical pharmacology, 56(1), 1998, pp. 105-112

Authors: MARQUEZ VE EZZITOUNI A RUSS P SIDDIQUI MA FORD H FELDMAN RJ MITSUYA H GEORGE C BARCHI JJ
Citation: Ve. Marquez et al., HIV-1 REVERSE-TRANSCRIPTASE CAN DISCRIMINATE BETWEEN 2 CONFORMATIONALLY LOCKED CARBOCYCLIC AZT TRIPHOSPHATE ANALOGS, Journal of the American Chemical Society, 120(12), 1998, pp. 2780-2789

Authors: WINTER H MAEDA Y MITSUYA H ZEMLICKA J
Citation: H. Winter et al., PHOSPHODIESTER AMIDATES OF UNSATURATED NUCLEOSIDE ANALOGS AS ANTI-HIVAGENTS, Nucleosides & nucleotides, 16(7-9), 1997, pp. 1341-1345

Authors: BROUWERS P HENDRICKS M LIETZAU JA PLUDA JM MITSUYA H BRODER S YARCHOAN R
Citation: P. Brouwers et al., EFFECT OF COMBINATION THERAPY WITH ZIDOVUDINE AND DIDANOSINE ON NEUROPSYCHOLOGICAL FUNCTIONING IN PATIENTS WITH SYMPTOMATIC HIV DISEASE - ACOMPARISON OF SIMULTANEOUS AND ALTERNATING REGIMENS, AIDS, 11(1), 1997, pp. 59-66

Authors: YUSA K KAVLICK MF KOSALARAKSA P MITSUYA H
Citation: K. Yusa et al., HIV-1 ACQUIRES RESISTANCE TO 2 CLASSES OF ANTIVIRAL DRUGS THROUGH HOMOLOGOUS RECOMBINATION, Antiviral research, 36(3), 1997, pp. 179-189

Authors: UCHIDA H MAEDA Y MITSUYA H
Citation: H. Uchida et al., HIV-1 PROTEASE DOES NOT PLAY A CRITICAL ROLE IN THE EARLY STAGES OF HIV-1 INFECTION, Antiviral research, 36(2), 1997, pp. 107-113

Authors: TANAKA M SRINIVAS RV UENO T KAVLICK MF HUI FK FRIDLAND A DRISCOLL JS MITSUYA H
Citation: M. Tanaka et al., IN-VITRO INDUCTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS RESISTANT TO 2'-BETA-FLUORO-2',3'-DIDEOXYADENOSINE, Antimicrobial agents and chemotherapy, 41(6), 1997, pp. 1313-1318

Authors: HUMPHREY RW OHAGEN A DAVIS DA FUKAZAWA T HAYASHI H HOGLUND S MITSUYA H YARCHOAN R
Citation: Rw. Humphrey et al., REMOVAL OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) PROTEASE INHIBITORS FROM PREPARATIONS OF IMMATURE HIV-1 VIRIONS DOES NOT RESULT IN AN INCREASE IN INFECTIVITY OR THE APPEARANCE OF MATURE MORPHOLOGY, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 1017-1023

Authors: WINTER H MAEDA Y UCHIDA H MITSUYA H ZEMLICKA J
Citation: H. Winter et al., PHOSPHODIESTER AMIDATES OF UNSATURATED NUCLEOSIDE ANALOGS - SYNTHESISAND ANTI-HIV ACTIVITY, Journal of medicinal chemistry, 40(14), 1997, pp. 2191-2195

Authors: MITSUYA H ENDO A KIKUCHI A NAKAI J SHOJI H TAKAHASHI M
Citation: H. Mitsuya et al., EFFECT OF GRAIN-SIZE ON INTERGRANULAR MAGNETOSTATIC COUPLING IN THIN-FILM MEDIA, Journal of applied physics, 81(8), 1997, pp. 4680-4682

Authors: KAWAGUCHI T NAGAKURA S HORIKAWA K IWAMOTO N ISHIHARA S HIDAKA M MITSUYA H NAKAKUMA H
Citation: T. Kawaguchi et al., FREQUENT MULTICLONALITY OF PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA, Blood, 90(10), 1997, pp. 2710-2710

Authors: HATA H MATSUZAKI H HARADA N YOSHIDA M SONOKI T NAGASAKI A KURIBAYASHI N KIMURA T MITSUYA H
Citation: H. Hata et al., EXPRESSION OF BCL-2 FAMILY PROTEINS IN PRIMARY HUMAN MYELOMA CELLS, Blood, 90(10), 1997, pp. 4095-4095

Authors: SONOKI T HATA H KURIBAYASHI N MATSUZAKI H NAGASAKI A YOSHIDA M MITSUYA H KAWAKITA M
Citation: T. Sonoki et al., EXPRESSION OF PRAD1 CYCLIN D1 IN PLASMA-CELL DYSCLASIA PATIENTS - INCIDENCE AND PROGNOSTIC-SIGNIFICANCE/, Blood, 90(10), 1997, pp. 1579-1579

Authors: UENO T MITSUYA H
Citation: T. Ueno et H. Mitsuya, COMPARATIVE ENZYMATIC STUDY OF HIV-1 REVERSE-TRANSCRIPTASE RESISTANT TO 2',3'-DIDEOXYNUCLEOTIDE ANALOGS USING THE SINGLE-NUCLEOTIDE INCORPORATION ASSAY, Biochemistry, 36(5), 1997, pp. 1092-1099

Authors: HUMPHREY RW DAVIS DA MITSUYA H YARCHOAN R
Citation: Rw. Humphrey et al., HIV VIRIONS PRODUCED BY CELLS TREATED WITH THE HIV-1 PROTEASE INHIBITOR KNI-272 DO NOT ACQUIRE INFECTIVITY AFTER VIRAL BUDDING, Journal of investigative medicine, 44(3), 1996, pp. 252-252

Authors: SHIRASAKA T KOJIMA E MITSUYA H
Citation: T. Shirasaka et al., STABILITY OF HIV-1 RNA IN BLOOD-SAMPLES FROM PATIENTS WITH HIV-1 INFECTION AS DETERMINED BY A QUANTITATIVE POLYMERASE CHAIN REACTION-BASED ASSAY, Clinical and diagnostic virology, 7(2), 1996, pp. 121-124

Authors: FOLI A SOGOCIO KM ANDERSON B KAVLICK M SAVILLE MW WAINBERG MA GU ZX CHERRINGTON JM MITSUYA H YARCHOAN R
Citation: A. Foli et al., IN-VITRO SELECTION AND MOLECULAR CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH REDUCED SENSITIVITY TO 9-[2-(PHOSPHONOMETHOXY)ETHYL]ADENINE (PMEA), Antiviral research, 32(2), 1996, pp. 91-98

Authors: AHLUWALIA GS GAG WY MITSUYA H JOHNS DG
Citation: Gs. Ahluwalia et al., 2',3'-DIDEHYDRO-3'-DEOXYTHYMIDINE - REGULATION OF ITS METABOLIC-ACTIVATION BY MODULATORS OF THYMIDINE-5'-TRIPHOSPHATE BIOSYNTHESIS, Molecular pharmacology, 50(1), 1996, pp. 160-165
Risultati: 1-25 | 26-50 | 51-75 | 76-87